Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 6 | 2021 | 251 | 2.080 |
Why?
|
| Proline | 5 | 2021 | 40 | 1.580 |
Why?
|
| HIV-1 | 15 | 2024 | 755 | 1.570 |
Why?
|
| MicroRNAs | 7 | 2021 | 518 | 1.500 |
Why?
|
| Proline Oxidase | 6 | 2015 | 11 | 1.120 |
Why?
|
| Dipeptidases | 2 | 2023 | 9 | 0.980 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2019 | 166 | 0.930 |
Why?
|
| Dopamine Uptake Inhibitors | 2 | 2017 | 83 | 0.900 |
Why?
|
| Virus Integration | 8 | 2024 | 65 | 0.860 |
Why?
|
| Sp1 Transcription Factor | 1 | 2023 | 46 | 0.820 |
Why?
|
| HIV Infections | 12 | 2024 | 2586 | 0.780 |
Why?
|
| Methamphetamine | 3 | 2021 | 166 | 0.770 |
Why?
|
| Amphetamine-Related Disorders | 2 | 2021 | 69 | 0.750 |
Why?
|
| Adenosine Triphosphate | 3 | 2021 | 206 | 0.740 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2015 | 279 | 0.640 |
Why?
|
| Glutamic Acid | 1 | 2021 | 131 | 0.630 |
Why?
|
| Homeostasis | 2 | 2021 | 192 | 0.630 |
Why?
|
| Nucleus Accumbens | 1 | 2020 | 100 | 0.610 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 306 | 0.580 |
Why?
|
| Biotin | 1 | 2018 | 24 | 0.570 |
Why?
|
| Signal Transduction | 3 | 2023 | 2157 | 0.540 |
Why?
|
| Apoptosis | 6 | 2021 | 1568 | 0.530 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 2676 | 0.470 |
Why?
|
| RNA, Messenger | 3 | 2018 | 1271 | 0.460 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2015 | 54 | 0.460 |
Why?
|
| Autophagy | 2 | 2015 | 140 | 0.440 |
Why?
|
| Cyclophilin A | 2 | 2024 | 19 | 0.420 |
Why?
|
| Cocaine-Related Disorders | 2 | 2015 | 102 | 0.420 |
Why?
|
| Virus Replication | 6 | 2024 | 318 | 0.410 |
Why?
|
| Protease Inhibitors | 2 | 2003 | 54 | 0.390 |
Why?
|
| Neurons | 2 | 2021 | 1263 | 0.380 |
Why?
|
| DNA, Viral | 5 | 2022 | 311 | 0.370 |
Why?
|
| Humans | 29 | 2024 | 43102 | 0.370 |
Why?
|
| Mice | 5 | 2023 | 6644 | 0.320 |
Why?
|
| 3' Untranslated Regions | 2 | 2020 | 82 | 0.310 |
Why?
|
| Brain | 1 | 2017 | 1472 | 0.300 |
Why?
|
| Capsid Proteins | 3 | 2024 | 76 | 0.300 |
Why?
|
| Malnutrition | 1 | 2009 | 44 | 0.290 |
Why?
|
| Enzyme Activation | 5 | 2017 | 462 | 0.260 |
Why?
|
| Thiazolidinediones | 2 | 2008 | 49 | 0.250 |
Why?
|
| Capsid | 3 | 2024 | 65 | 0.240 |
Why?
|
| Chromans | 1 | 2005 | 16 | 0.240 |
Why?
|
| PPAR gamma | 1 | 2005 | 55 | 0.230 |
Why?
|
| Protein Binding | 4 | 2024 | 1082 | 0.230 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2021 | 220 | 0.230 |
Why?
|
| Binding Sites | 3 | 2020 | 671 | 0.220 |
Why?
|
| Animals | 6 | 2023 | 16992 | 0.220 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2004 | 12 | 0.220 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 70 | 0.210 |
Why?
|
| Collagen | 2 | 2023 | 181 | 0.210 |
Why?
|
| Endopeptidase K | 1 | 2003 | 4 | 0.210 |
Why?
|
| Up-Regulation | 3 | 2015 | 536 | 0.210 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2024 | 91 | 0.210 |
Why?
|
| Protein Folding | 1 | 2004 | 123 | 0.200 |
Why?
|
| Disease Progression | 3 | 2015 | 667 | 0.200 |
Why?
|
| Reactive Oxygen Species | 3 | 2015 | 532 | 0.200 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2023 | 97 | 0.200 |
Why?
|
| Alkalies | 1 | 2002 | 5 | 0.190 |
Why?
|
| Histone Code | 1 | 2022 | 13 | 0.190 |
Why?
|
| Substance-Related Disorders | 1 | 2010 | 830 | 0.190 |
Why?
|
| Nucleosomes | 1 | 2022 | 30 | 0.190 |
Why?
|
| Actinobacteria | 1 | 2002 | 14 | 0.190 |
Why?
|
| Chromosomes, Human | 1 | 2022 | 37 | 0.190 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 216 | 0.190 |
Why?
|
| Mutation | 3 | 2020 | 1177 | 0.180 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 1070 | 0.180 |
Why?
|
| Exodeoxyribonucleases | 1 | 2021 | 17 | 0.180 |
Why?
|
| HIV Integrase | 2 | 2022 | 22 | 0.180 |
Why?
|
| Histones | 1 | 2022 | 197 | 0.170 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2021 | 17 | 0.170 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 74 | 0.170 |
Why?
|
| Cricetulus | 1 | 2021 | 82 | 0.170 |
Why?
|
| CHO Cells | 1 | 2021 | 123 | 0.170 |
Why?
|
| RNA Interference | 2 | 2021 | 247 | 0.170 |
Why?
|
| Host-Pathogen Interactions | 2 | 2023 | 209 | 0.170 |
Why?
|
| Acute Disease | 1 | 2021 | 155 | 0.160 |
Why?
|
| Injections, Intraperitoneal | 1 | 2020 | 60 | 0.160 |
Why?
|
| Cell Death | 1 | 2021 | 278 | 0.160 |
Why?
|
| Immunity, Innate | 1 | 2021 | 171 | 0.160 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2020 | 21 | 0.160 |
Why?
|
| RNA, Viral | 2 | 2019 | 321 | 0.160 |
Why?
|
| Models, Animal | 1 | 2020 | 151 | 0.160 |
Why?
|
| Blood | 1 | 2019 | 37 | 0.160 |
Why?
|
| Phosphoproteins | 1 | 2021 | 206 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 189 | 0.150 |
Why?
|
| Bacterial Proteins | 1 | 2004 | 595 | 0.150 |
Why?
|
| Oxidation-Reduction | 2 | 2015 | 457 | 0.150 |
Why?
|
| Semen | 1 | 2019 | 57 | 0.150 |
Why?
|
| Phenylalanine | 1 | 2019 | 25 | 0.150 |
Why?
|
| Microvessels | 1 | 2019 | 31 | 0.150 |
Why?
|
| Transcription Factors | 1 | 2023 | 735 | 0.150 |
Why?
|
| Down-Regulation | 1 | 2020 | 456 | 0.140 |
Why?
|
| Proteome | 1 | 2019 | 152 | 0.140 |
Why?
|
| Exosomes | 1 | 2019 | 126 | 0.130 |
Why?
|
| Annexin A5 | 1 | 2017 | 27 | 0.130 |
Why?
|
| Cell Nucleus | 4 | 2023 | 383 | 0.130 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2017 | 59 | 0.130 |
Why?
|
| Indoles | 1 | 2019 | 187 | 0.130 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2017 | 92 | 0.130 |
Why?
|
| Virion | 2 | 2015 | 75 | 0.130 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 173 | 0.130 |
Why?
|
| Transfection | 1 | 2018 | 532 | 0.130 |
Why?
|
| Proteomics | 1 | 2019 | 378 | 0.130 |
Why?
|
| Male | 4 | 2021 | 23409 | 0.130 |
Why?
|
| Neuroblastoma | 1 | 2017 | 136 | 0.120 |
Why?
|
| Cattle | 1 | 2017 | 498 | 0.120 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2015 | 12 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2019 | 329 | 0.120 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2015 | 51 | 0.120 |
Why?
|
| Doxycycline | 1 | 2015 | 32 | 0.120 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 95 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 968 | 0.110 |
Why?
|
| Endometrium | 1 | 2015 | 59 | 0.110 |
Why?
|
| Fluoresceins | 2 | 2004 | 29 | 0.110 |
Why?
|
| Cell Line | 4 | 2019 | 1410 | 0.110 |
Why?
|
| Adrenergic Agents | 1 | 2013 | 8 | 0.100 |
Why?
|
| Cell Separation | 1 | 2014 | 94 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2014 | 411 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1019 | 0.090 |
Why?
|
| Reverse Transcription | 2 | 2024 | 23 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1869 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 1124 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 432 | 0.090 |
Why?
|
| Anti-HIV Agents | 2 | 2019 | 486 | 0.090 |
Why?
|
| Mitochondria | 1 | 2015 | 523 | 0.090 |
Why?
|
| Dinucleoside Phosphates | 1 | 2011 | 11 | 0.090 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2011 | 35 | 0.090 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2011 | 57 | 0.090 |
Why?
|
| Drug Resistance, Viral | 1 | 2011 | 67 | 0.080 |
Why?
|
| Stress, Physiological | 2 | 2009 | 172 | 0.080 |
Why?
|
| Proviruses | 2 | 2024 | 35 | 0.080 |
Why?
|
| Virus Latency | 1 | 2010 | 49 | 0.080 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2010 | 74 | 0.080 |
Why?
|
| Rats | 1 | 2017 | 3735 | 0.080 |
Why?
|
| Catalysis | 2 | 2008 | 187 | 0.070 |
Why?
|
| Sirolimus | 1 | 2009 | 70 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 458 | 0.070 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2008 | 3 | 0.070 |
Why?
|
| Ligands | 2 | 2008 | 388 | 0.070 |
Why?
|
| Glucose | 1 | 2009 | 244 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 592 | 0.070 |
Why?
|
| Food | 1 | 2008 | 103 | 0.070 |
Why?
|
| Anilides | 1 | 2005 | 28 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2005 | 74 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 314 | 0.060 |
Why?
|
| Pregnancy | 1 | 2010 | 1772 | 0.060 |
Why?
|
| Plasmids | 1 | 2005 | 244 | 0.060 |
Why?
|
| Cyclosporine | 1 | 2024 | 36 | 0.050 |
Why?
|
| Buffers | 1 | 2004 | 17 | 0.050 |
Why?
|
| Protein Denaturation | 1 | 2004 | 41 | 0.050 |
Why?
|
| Dimerization | 1 | 2004 | 112 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 652 | 0.050 |
Why?
|
| Disulfides | 1 | 2004 | 95 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2005 | 883 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2009 | 512 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 526 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 184 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2002 | 168 | 0.050 |
Why?
|
| Methylation | 1 | 2022 | 119 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2003 | 416 | 0.050 |
Why?
|
| Lysine | 1 | 2022 | 119 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2023 | 190 | 0.050 |
Why?
|
| Kinetics | 1 | 2003 | 695 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2002 | 141 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 388 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2021 | 46 | 0.040 |
Why?
|
| Chromatin | 1 | 2022 | 186 | 0.040 |
Why?
|
| Time Factors | 1 | 2005 | 1857 | 0.040 |
Why?
|
| Hela Cells | 1 | 2021 | 376 | 0.040 |
Why?
|
| Neoplasms | 2 | 2008 | 1377 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 184 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2019 | 128 | 0.040 |
Why?
|
| HIV Seropositivity | 1 | 2019 | 196 | 0.030 |
Why?
|
| Nucleoproteins | 1 | 2017 | 15 | 0.030 |
Why?
|
| Cytokines | 1 | 2021 | 678 | 0.030 |
Why?
|
| Monocytes | 1 | 2019 | 277 | 0.030 |
Why?
|
| Young Adult | 2 | 2019 | 5080 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2017 | 154 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2017 | 119 | 0.030 |
Why?
|
| Metrorrhagia | 1 | 2015 | 8 | 0.030 |
Why?
|
| Vesiculovirus | 1 | 2015 | 5 | 0.030 |
Why?
|
| Phytohemagglutinins | 1 | 2015 | 13 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 1596 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 234 | 0.030 |
Why?
|
| Models, Biological | 2 | 2008 | 712 | 0.030 |
Why?
|
| Female | 2 | 2015 | 24698 | 0.030 |
Why?
|
| Endocytosis | 1 | 2015 | 118 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 249 | 0.030 |
Why?
|
| Viral Load | 1 | 2015 | 348 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 12222 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 1600 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 13872 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 1621 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 570 | 0.020 |
Why?
|
| Pyrroline Carboxylate Reductases | 1 | 2008 | 1 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 2008 | 35 | 0.020 |
Why?
|
| PPAR delta | 1 | 2008 | 2 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2008 | 30 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2008 | 100 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2008 | 97 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2008 | 204 | 0.020 |
Why?
|
| Adolescent | 1 | 2015 | 6081 | 0.010 |
Why?
|
| Inflammation | 1 | 2008 | 758 | 0.010 |
Why?
|